BIOINFORMATIC CHARACTERIZATION OF DIFFERENTIAL PROTEINS IN THE HIPPOCAMPUS OF TS65DN: A MOUSE MODEL OF DOWN SYNDROME

被引:0
|
作者
Zhang, Bin [1 ]
Kong, Jing [1 ]
Shi, Ye [1 ]
Wang, Qiu-Wei [1 ]
Shao, S. Hi-He [2 ]
Yu, Bin [1 ,2 ]
机构
[1] Nanjing Med Univ, Changzhou Woman & Children Hlth Hosp, Changzhou 213003, Jiangsu, Peoples R China
[2] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Microbiol, Zhenjiang 212013, Jiangsu, Peoples R China
关键词
Down syndrome; iTRAQ; bioinformatics analysis; Ts65Dn; hippocampus; INSULIN; RECEPTORS; FETUSES; SYSTEM; NUMBER; BRAIN;
D O I
10.2298/ABS1403157Z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Down syndrome (DS) is characterized by mental retardation and the development of Alzheimer's disease (AD). The reason for this development is not yet clear. Ts65Dn mice were used in this study. We collected their hippocampi and identified protein biomarkers using isobaric tags for relative and absolute quantitation (iTRAQ). We described the biochemical characteristics of proteins and explored their complicated network using GOA, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and network analysis. There were 374 significant differential proteins in the hippocampi of Ts65Dn mice. These were mainly binding proteins, related to single-organism and cellular processes. KEGG pathway analysis revealed that the insulin-signaling pathway was enriched with DS. Using PAJEK, a network of protein interactions was constructed and the top ten hub proteins were FYN, YBX1, VIM, PRKACA, EWSR1, H2AFX, CACNA1A, PTN, TFCP2L1 and CRKL. Through preliminarily discovered differentially expressed proteins by iTRAQ and bioinformatics analysis, we concluded that these proteins could be closely related to the neurological deficits of DS.
引用
收藏
页码:1157 / 1162
页数:6
相关论文
共 50 条
  • [31] Proteomic analysis of cardiovascular development in the Ts65Dn Down Syndrome mouse model
    Moore, Clara S.
    Kelly, Erik
    Franca, Arianna
    DEVELOPMENTAL BIOLOGY, 2011, 356 (01) : 174 - 175
  • [32] Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
    Kirsammer, Gina
    Jilani, Sarah
    Liu, Hui
    Davis, Elizabeth
    Gurbuxani, Sandeep
    Le Beau, Michelle M.
    Crispino, John D.
    BLOOD, 2008, 111 (02) : 767 - 775
  • [33] Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome
    Ravaioli, Francesco
    Stagni, Fiorenza
    Guidi, Sandra
    Pirazzini, Chiara
    Garagnani, Paolo
    Silvani, Alessandro
    Zoccoli, Giovanna
    Bartesaghi, Renata
    Bacalini, Maria Giulia
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [34] Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome
    Dierssen, M
    Vallina, IF
    Baamonde, C
    GarciaCalatayud, S
    Lumbreras, MA
    Florez, J
    BRAIN RESEARCH, 1997, 749 (02) : 238 - 244
  • [35] Hippocampal and cerebellar BDNF levels in the Ts65Dn mouse model of Down syndrome
    Roberson, Robin
    Kuddo, Thea
    Caballero, Madeline
    Horowitz, Kari
    Spong, Catherine Y.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : S320 - S320
  • [36] Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome
    Marland, Jamie R. K.
    Smillie, Karen J.
    Cousin, Michael A.
    PLOS ONE, 2016, 11 (01):
  • [37] Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome
    Liu, DP
    Schmidt, C
    Billings, M
    Davisson, MT
    BIOTECHNIQUES, 2003, 35 (06) : 1170 - +
  • [38] Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome
    Wen-Bo Zhou
    Zong-Ning Miao
    Bin Zhang
    Wei Long
    Fang-Xiu Zheng
    Jing Kong
    Bin Yu
    NeuralRegenerationResearch, 2019, 14 (04) : 613 - 620
  • [39] Postnatal lethality and cardiac anomalies in the Ts65Dn Down Syndrome mouse model
    Clara S. Moore
    Mammalian Genome, 2006, 17
  • [40] APP accumulation and inflammation in the Ts65dn mouse, a model for Down's syndrome
    Lockrow, J
    Willis, L
    Granholm, AC
    Sambamurti, K
    EXPERIMENTAL NEUROLOGY, 2006, 198 (02) : 578 - 578